Commentary on 'Exploration of suitable pharmacodynamic parameters for acarbose bioequivalence evaluation: A series of clinical trials with branded acarbose' by Jie Huang et al.

Peijue Zhang Jieon Lee Kairui Feng Andrew Babiskin Miyoung Yoon Lanyan Fang Liang Zhao

Br J Clin Pharmacol

Division of Quantitative Methods & Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland, USA.

Published: September 2024

Download full-text PDF	Source
http://dx.doi.org/10.1111/bcp.16148	DOI Listing

Publication Analysis

Top Keywords

commentary 'exploration

'exploration suitable

suitable pharmacodynamic

pharmacodynamic parameters

parameters acarbose

acarbose bioequivalence

bioequivalence evaluation

evaluation series

series clinical

clinical trials

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!